Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20241028063524N2Phase 3Completed
Phase 3, randomised, double-blind trial in post-dural puncture headache (PDPH) comparing Ondansetron, Paracetamol and Ondansetron + paracetamol (3 arms). Primary endpoint: Incidence of post-dural puncture headache. Started Feb 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20241028063524N2.